Product Details
Product Name:
PDP-EA |
CAS No.:
861891-72-7 |
Purity:
98.06% |
Supply Ability:
10g |
Release date:
2024/11/19 |
Product Introduction
Bioactivity
Name | PDP-EA |
Description | PDP-EA is an activator of fatty acid amide hydrolase(FAAH) and enhances the amidohydrolase activity of FAAH. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 4.06 mg/mL (10 mM), Sonication is recommended.
|
Keywords | N-Acylethanolamines | PDPEA | fatty acid amide hydrolase | PDP EA | PDP-EA | Inhibitor | inhibit | FAAH |
Inhibitors Related | WWL 154 | VU534 | Biochanin A | 2-Chlorophenylboronic acid | AA38-3 | Carprofen | Dual FAAH/sEH-IN-1 | FAAH inhibitor 1 | LY2183240 | PF 750 | MM-433593 | JNJ-42165279 |
Related Compound Libraries | Bioactive Compound Library | Neuronal Signaling Compound Library | Metabolism Compound Library | Lipid Metabolism Compound Library | Bioactive Compounds Library Max | Anti-Metabolism Disease Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:2454181-83-8
$67.00 / 1mg
-
CAS:883944-52-3
$33.00 / 1mg
-
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$2500.00/100mg |
VIP1Y
|
TargetMol Chemicals Inc.
|
2024-10-28 |
|
$53.00/5mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-10-28 |
|
$0.00/250mg |
VIP1Y
|
Xian confluore Biological Technology Co., Ltd.
|
2024-03-30 |